At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SLXN Silexion Therapeutics Corp
Trading 04-02 14:13:00 EDT
1.21
-0.01
-0.82%
High1.26
Low1.19
Vol12.54K
Open1.23
D1 Closing1.22
Amplitude5.73%
Mkt Cap4.03M
Tradable Cap3.62M
Total Shares3.33M
T/O15.31K
T/O Rate0.42%
Tradable Shares3.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Silexion Therapeutics removes Ilan Levin from board; change effective immediately
Silexion Therapeutics Receives Approval From Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of Sil204 in Locally Advanced Pancreatic Cancer
Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York.